US · Healthcare

Institute of Biomedical Research Corp (MRES)

Biotechnology

Institute of Biomedical Research Corp (MRES) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for MRES

P/E ratio

18.00

Institute of Biomedical Research Corp (MRES) — FAQ

What is MRES's P/E ratio?

The price-to-earnings (P/E) ratio for Institute of Biomedical Research Corp (MRES) is 18.00 (data as of 2026-03-24).

Does Institute of Biomedical Research Corp pay a dividend?

Dividend yield is not available in the current snapshot for Institute of Biomedical Research Corp (MRES). Check the MyAverix Finance app for the latest dividend data.

What sector is Institute of Biomedical Research Corp in?

Institute of Biomedical Research Corp (MRES) is classified in the Healthcare sector (Biotechnology industry).

What exchange is MRES listed on?

MRES is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)